Business Wire

CLEO

20.5.2019 09:02:06 CEST | Business Wire | Press release

Share
Cleo to Showcase End-to-End Approach to Ecosystem Integration at Gartner AADI in London

Gartner’s Application Architecture, Development & Integration (AADI) Summit returns to London to provide strategies for solving the pervasive challenges of orchestrating workflows between external B2B and application ecosystems with internal business systems. Cleo , the global leader in ecosystem integration solutions, will be exhibiting in Booth S3 to demonstrate how successful organisations leverage its “outside-in” approach to create seamless end-to-end workflows and help optimize business processes.

The Gartner AADI 2019 event , taking place 20-21 May at Park Plaza Westminster, is designed to empower IT and business professionals in transforming their application architecture, agile development, and integration strategies. The event’s focus on application strategies and data processes in the era of the cloud highlights the need for better ways to execute application integration, an inescapable challenge in today’s business landscape.

According to the 2019 State of Ecosystem and Integration Application Report , integration is a constant battle for organisations, with 25% of companies struggling to integrate new applications with legacy systems. All told, unreliable partner and application integrations are costing companies approximately $500,000 every year. Cleo will showcase at the Gartner AADI summit how to solve these challenges using an innovative approach that integrates the dynamic ecosystem of people, partners, customers, systems, applications, and things and supports the critical data flows driving revenue.

About Cleo Integration Cloud

Today’s data exchange requirements often are dictated by the partners, suppliers, customers, vendors, and all their respective technologies comprising a modern business ecosystem, and it demands a change in how we view traditional integration patterns. Conference-goers visiting the Cleo booth will learn hands-on about the business benefits of technology embracing this fresh POV – integration that prioritises external customer and trading partner data processes and integrates them seamlessly into internal workflows – via the Cleo Integration Cloud platform.

Cleo’s flagship offering is a single, hybrid integration platform enabling organisations to connect, transform, integrate, orchestrate, and analyse end-to-end application, B2B, cloud, and data integrations for improved visibility across global business ecosystems. Cleo Integration Cloud facilitates the heavy lifting of integration while also providing dynamic dashboards to empower technical and business users to make better decisions, create stronger relationships with trading partners, and accelerate growth as data requirements evolve. The result is end-to-end transparency throughout internal networks and external business ecosystems, which enables organisations to maximise the value of their application investments.

Agenda Highlights

The opening keynote for this year’s Gartner AADI summit is titled, “Optimize, Integrate and Transform to Achieve Your Digital Future” and features Gartner’s Elizabeth Golluscio, managing vice president, Keith Guttridge, senior director analyst, and Mark O'Neill, VP analyst. The speakers will explore how organisations pursuing digital transformation must apply modern digital application and integration strategies to advance those initiatives.

The agenda also features a number of topics spanning cloud integration challenges, strategic application trends, modernising core systems, postmodern ERP integration, and how smart application integration delivers next-generation customer experiences. The nature of the 2019 agenda further emphasizes the value an ecosystem-driven approach can have in designing application integration processes that support innovation, align with business goals, and deliver competitive advantage.

“Organisations are at a tipping point in how they integrate all the ERPs, CRMs, e-commerce, and other business-critical applications they deploy almost daily,” said Cleo CMO Tushar Patel . “It’s individual departments and lines of business that are driving technology investment, rather than the traditional IT teams, and it requires a change in how they approach application integration. Today’s integration technology should give companies a path to optimising their core business processes while solving external B2B and internal application integration challenges simultaneously.”

Patel adds: “The companies treating application and B2B interactions as separate, disparate business processes are leaving value on the table and will get left behind.”

Come see Cleo at Booth S3 for a Cleo-themed cocktail – an “Ecosystem Integration Elixir” – and to learn how Cleo customers are achieving success every day with Cleo Integration Cloud. To learn more about Cleo, and how Cleo Integration Cloud can help your business, visit our website – www.cleo.com .

For more insights on what to expect at the event, read the blog titled, “Ecosystem Integration & Value Beyond the Gartner AADI London Agenda.”

About Gartner AADI 2019

The Gartner Application Architecture, Development & Integration Summit 2019 is designed for application leaders to learn about crafting leading-edge applications, architectures and strategies leveraging microservices, DevOps and artificial intelligence, and more. Attendees can gain intensive learning and actionable insight as they plan to drive growth through digital business transformation.

About Cleo

Cleo is an ecosystem integration software company focused on business outcomes, ensuring each customer’s potential is realized by delivering solutions that make it easy to discover and create value through the movement and integration of enterprise data. Cleo gives customers a strategic, “outside-in” visibility into the critical end-to-end business flows happening across their ecosystems of partners and customers, marketplaces, and internal cloud and on-premise applications. Our solutions empower teams to drive business agility, accelerate onboarding, facilitate modernisation of key business processes, and capture new revenue streams by reimagining and remastering their digital ecosystem through robust application, B2B, and data integration technologies. For more information, visit www.cleo.com or call +1.815.282.7695.

Contact:

Media Contacts Matt Torman Senior Manager, Marketing Communications Cleo +1.815.282.7610

Drew Smith Senior Account Manager 10Fold Communications (for Cleo) +1.415.800.5374

Link:

ClickThru

Social Media:

https://www.facebook.com/CleoCommunications

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye